Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIndigestion is one of the most commonly reported side effects of Wegovy (semaglutide), particularly in the first weeks of treatment or after each dose increase. It tends to feel like upper-stomach discomfort, bloating, or a burning sensation after eating — and it's caused directly by how the medicine works in your gut. For most people it settles, but knowing what to expect makes a real difference. Wegovy is a prescription-only medicine; a qualified prescriber assesses whether it's appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That burning pressure after a meal is one of the more frustrating parts of the early weeks on Wegovy. You're doing everything right (smaller portions, slower eating) and yet there it is. The discomfort is real, and it's not a sign that something has gone wrong.
What's happening is fairly straightforward. Semaglutide activates GLP-1 receptors in your gut and brain, which slows gastric emptying as part of how it reduces appetite. Food stays in your stomach longer. That extra dwell time raises pressure at the top of the stomach, and for some people acid reflux or indigestion follows. The slowing of digestion that makes Wegovy effective is also the mechanism behind these symptoms.
The timing matters. Indigestion with Wegovy tends to peak in the first couple of weeks after starting or after a dose increase, then gradually settles as your body adjusts. It's not a signal that you're intolerant; it's a signal that your digestive system is recalibrating. Most people find the pattern predictable once they've seen it once — uncomfortable, but manageable.
If you're feeling disheartened right now, that's fair. Starting a new treatment and immediately feeling worse in one way is annoying. The good news is that the GI effects of semaglutide, which you can read more about on our dedicated page, are usually temporary and rarely severe enough to warrant stopping.
Practical changes often make a bigger difference than people expect. The goal is to reduce the volume and richness of each meal so your slowed stomach isn't overloaded.
Eat smaller amounts, more often, rather than two or three large meals. Very fatty foods slow gastric emptying further and are the most consistent trigger for acid symptoms on semaglutide, temporarily cutting back on rich sauces, fried food and full-fat dairy often helps quickly. Spicy food and carbonated drinks can irritate the oesophagus directly, so reducing both during flares is worth trying. Eating slowly and stopping before you feel full is not just good advice for weight management; it materially reduces how much pressure builds in the stomach.
After eating, stay upright for at least an hour. Lying down immediately after a meal is the most reliable way to make reflux worse, and it's especially relevant on Wegovy because gastric emptying is already sluggish. If overnight reflux is a problem, raising the head of the bed by a few inches or using an extra pillow can help.
Over-the-counter antacids are generally considered safe alongside semaglutide, but because Wegovy affects how quickly the stomach processes anything you swallow, timing and interactions are worth discussing with your prescriber or pharmacist before adding any regular medication. There's useful background on how semaglutide affects digestion more broadly on our page covering gastric emptying on Wegovy.
Most indigestion on semaglutide is mild to moderate and settles with the adjustments above. There are situations, though, where you should contact your prescriber or seek urgent medical attention rather than waiting it out.
Severe or persistent stomach pain (particularly pain that radiates to your back) is not typical indigestion and should be assessed promptly. The MHRA has highlighted acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the key distinguishing symptom is intense upper-abdominal or back pain, often with vomiting, that doesn't ease. If your symptoms fit that pattern, seek medical help the same day. You can report unexpected side effects directly through the MHRA Yellow Card scheme.
If indigestion is so severe it stops you eating or drinking, or you're losing weight faster than expected alongside the GI symptoms, tell your prescriber. It may be worth pausing or delaying the next dose increase to give your gut more time at the current level, something a prescriber can advise on after reviewing your progress. For a fuller picture of what semaglutide is licensed to treat and the conditions it suits, the page on semaglutide indications is a useful starting point.
Digestive enzyme supplements are sometimes discussed in online communities as a way to ease GI symptoms on GLP-1 medicines; our page on digestive enzymes and Wegovy covers what the evidence actually says.
Indigestion sits within a wider cluster of GI side effects that semaglutide commonly causes, including nausea, constipation, diarrhoea and burping. They share the same root cause: the medicine's effect on gut motility. Individual experiences vary considerably, some people get mainly nausea, others reflux, others constipation. Many get a rotation of all three in the early weeks.
The NHS semaglutide page lists these effects clearly, and the clinical trial data backs up the pattern: GI side effects were the most common reason participants needed dose adjustments in the STEP trials. That doesn't mean everyone experiences them severely, but it does mean they're expected, monitored, and built into how the treatment schedule is designed.
If you're considering Wegovy or currently on another weight-management treatment, the weight-loss treatments overview gives broader context on how the options compare. And if you've decided Wegovy is what you want to explore, check your eligibility with our prescribers, a free consultation with a GPhC-registered clinician at our registered UK pharmacy.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.